Pipeline Analysis for Malaria Therapeutic Development, H2 2016 No of Pages – 413 Publishing Date - November, 2016 Browse detailed TOC, Tables, Figures and Charts in Global Serial Device Server Consumption 2016 Market Research Report athttp://www.marketresearchhub.com/report/malaria-pipeline-review-h2-2016-report.html
A latest pharmaceutical and healthcare disease pipeline guide by Global Markets Direct has been launched and added to the vast archive of Market Research Hub (MRH). The report is titled “Malaria - Pipeline Review, H2 2016”, provides comprehensive information and pipeline landscape on the therapeutic development for Malaria with relative analysis at various stages which include drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The research study of 413 pages, built using proprietary databases along with latest updates\and featured news & press releases from various university sites and industry specific third party sources.
The report begins with the detailed introduction of malaria disease along with its cure and symptoms. . Malaria is a life-threatening blood disease caused by a parasite that is transmitted to humans after the bit of an infected female Anopheles mosquito. Request for Free Sample Report
The disease is infectious for every individual but mostly increases risk for people such asyoung children and infants, travelers coming from areas with no malaria, pregnant women and their unborn children. Every year, 350 to 500 million cases of malaria occur world-wide and over one million people die due to malaria. Symptoms of Malaria include- fever, headache, sweat, fatigue, enlarged spleen, nausea and vomiting. Finest treatment for the disease includes anti-malarial medicines and healthy lifestyle. Further, pipeline guide also features descriptive drug profiles for the pipeline elements containing product description, descriptive licensing and collaboration details along with R&D and other developmental activities. The guide also covers the pipeline products that are based on numerous stages of development ranging from pre-registration till discovery and undisclosed stages. Following are some of the prime pharmaceutical drugs used by emerging players to prevent malaria
Atovaquone proguanil Doxycycline Mefloquine Chloroquine Primaquine
The Malaria pipeline guide also reviews the key players involved in therapeutic development for malaria and features inactive and discontinued projects. Additionally, various dynamic tracking process also ensures that most recent developments are captured on a real time basis. Some of the key players mentioned in the report are:
Acetylon Pharmaceuticals, Inc. Cellceutix Corporation Chong Kun Dang Pharmaceutical Corp. Cilian AG SBI Pharmaceuticals Co., Ltd.
The buyer can also gain benefits and develop tactical initiatives by understanding the focus areas of leading companies. In fact, they can also design in-licensing and out-licensing policies by identifying future partners with attractive projects to expand business potential.
Request for Free Sample Report
Table of ContentsTable of Contents 2 Introduction 6 Malaria Overview 7 Therapeutics Development 8 Malaria - Therapeutics under Development by Companies 10 Malaria - Therapeutics under Investigation by Universities/Institutes 15 Malaria - Pipeline Products Glance 19 Malaria - Products under Development by Companies 22 Malaria - Products under Investigation by Universities/Institutes 29 Malaria - Companies Involved in Therapeutics Development 36 Malaria - Therapeutics Assessment 99 Drug Profiles 111 Malaria - Dormant Projects 362 Malaria - Discontinued Products 375 Malaria - Product Development Milestones 377 Appendix 390
List of Tables Number of Products under Development for Malaria, H2 2016 30 Number of Products under Development for Malaria - Comparative Analysis, H2 2016 31 Number of Products under Development by Companies, H2 2016 32 Number of Products under Development by Companies, H2 2016 (Contd..1) 33 Number of Products under Development by Companies, H2 2016 (Contd..2) 34 Number of Products under Development by Companies, H2 2016 (Contd..3) 35 Number of Products under Development by Companies, H2 2016 (Contd..4) 36 Number of Products under Investigation by Universities/Institutes, H2 2016 37
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 38 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 39 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..3) 40 Comparative Analysis by Late Stage Development, H2 2016 41 Comparative Analysis by Clinical Stage Development, H2 2016 42 Comparative Analysis by Early Stage Development, H2 2016 43 Products under Development by Companies, H2 2016 44 Products under Development by Companies, H2 2016 (Contd..1) 45 Products under Development by Companies, H2 2016 (Contd..2) 46 Products under Development by Companies, H2 2016 (Contd..3) 47 Products under Development by Companies, H2 2016 (Contd..4) 48 Products under Development by Companies, H2 2016 (Contd..5) 49 Products under Development by Companies, H2 2016 (Contd..6) 50 Products under Investigation by Universities/Institutes, H2 2016 51 Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 52 Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 53 Products under Investigation by Universities/Institutes, H2 2016 (Contd..3) 54 Products under Investigation by Universities/Institutes, H2 2016 (Contd..4) 55 Products under Investigation by Universities/Institutes, H2 2016 (Contd..5) 56 Products under Investigation by Universities/Institutes, H2 2016 (Contd..6) 57 Malaria - Pipeline by 4SC AG, H2 2016 58 Malaria - Pipeline by Acetylon Pharmaceuticals, Inc., H2 2016 59 Malaria - Pipeline by Actelion Ltd, H2 2016 60 Malaria - Pipeline by Agilvax Inc, H2 2016 61 Malaria - Pipeline by Akshaya Bio Inc., H2 2016 62 Malaria - Pipeline by Allergy Therapeutics Plc, H2 2016 63 Malaria - Pipeline by Amura Holdings Limited, H2 2016 64 Malaria - Pipeline by Anacor Pharmaceuticals, Inc., H2 2016 65 Malaria - Pipeline by Artificial Cell Technologies, Inc., H2 2016 66 Malaria - Pipeline by AstraZeneca Plc, H2 2016 67 Malaria - Pipeline by Bharat Biotech International Limited, H2 2016 68 Malaria - Pipeline by Callaghan Innovation Research Ltd., H2 2016 69 Malaria - Pipeline by Carna Biosciences, Inc., H2 2016 70 Malaria - Pipeline by CEL-SCI Corporation, H2 2016 71 Malaria - Pipeline by Celgene Corporation, H2 2016 72 Malaria - Pipeline by Cellceutix Corporation, H2 2016 73 Malaria - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2016 74 Malaria - Pipeline by Cilian AG, H2 2016 75 Malaria - Pipeline by Daiichi Sankyo Company, Limited, H2 2016 76 Malaria - Pipeline by DesignMedix, Inc., H2 2016 77
Malaria - Pipeline by Eisai Co., Ltd., H2 2016 78 Malaria - Pipeline by GenVec, Inc., H2 2016 79 Malaria - Pipeline by Genzyme Corporation, H2 2016 80 Malaria - Pipeline by GlaxoSmithKline Plc, H2 2016 81 Malaria - Pipeline by Hager Biosciences, LLC, H2 2016 82 Malaria - Pipeline by Horizon Pharma Plc, H2 2016 83 Malaria - Pipeline by iBio, Inc., H2 2016 84 Malaria - Pipeline by Imaxio SA, H2 2016 85 Malaria - Pipeline by Immtech Pharmaceuticals, Inc., H2 2016 86 Malaria - Pipeline by Immunovaccine Inc, H2 2016 87 Malaria - Pipeline by IPCA Laboratories Limited, H2 2016 88 Malaria - Pipeline by IRBM Science Park SpA, H2 2016 89 Malaria - Pipeline by Jenrin Discovery, Inc., H2 2016 90 Malaria - Pipeline by Jomaa Pharma GmbH, H2 2016 91 Malaria - Pipeline by Kancera AB, H2 2016 92 Malaria - Pipeline by Kymab Limited, H2 2016 93 Malaria - Pipeline by Lipocure Ltd., H2 2016 94 Malaria - Pipeline by Lipotek Pty Ltd., H2 2016 95 Malaria - Pipeline by LondonPharma Ltd, H2 2016 96 Malaria - Pipeline by Merck & Co., Inc., H2 2016 97 Malaria - Pipeline by Merck KGaA, H2 2016 98 Malaria - Pipeline by MerLion Pharmaceuticals Pte Ltd, H2 2016 99 Malaria - Pipeline by Microbiotix, Inc., H2 2016 100 Malaria - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016 101 Malaria - Pipeline by Mucosis B.V., H2 2016 102
Request for Free Sample Report
Malaria - Pipeline by Mymetics Corporation, H2 2016 103 Malaria - Pipeline by Novartis AG, H2 2016 104 Malaria - Pipeline by PaxVax, Inc., H2 2016 105 Malaria - Pipeline by Pfenex Inc., H2 2016 106 Malaria - Pipeline by Pfizer Inc., H2 2016 107 Malaria - Pipeline by Protein Potential, LLC, H2 2016 108 Malaria - Pipeline by Rodos BioTarget GmbH, H2 2016 109 Malaria - Pipeline by Sanaria Inc., H2 2016 110 Malaria - Pipeline by Sanofi, H2 2016 111 Malaria - Pipeline by SBI Pharmaceuticals Co., Ltd., H2 2016 112 Malaria - Pipeline by Selecta Biosciences, Inc., H2 2016 113 Malaria - Pipeline by Sigma-Tau S.p.A., H2 2016 114 Malaria - Pipeline by Takeda Pharmaceutical Company Limited, H2 2016 115 Malaria - Pipeline by Telormedix SA, H2 2016 116
Malaria - Pipeline by Tomegavax, Inc., H2 2016 117 Malaria - Pipeline by VLP Biotech, Inc., H2 2016 118 Malaria - Pipeline by VLP Therapeutics, LLC, H2 2016 119 Malaria - Pipeline by Zydus Cadila Healthcare Limited, H2 2016 120 Assessment by Monotherapy Products, H2 2016 121 Assessment by Combination Products, H2 2016 122 Number of Products by Stage and Target, H2 2016 124
Ask For Discount Report Details – Date of Publishing – Nov. 2016 No of Pages – 413 Single User License – $2000 Multiple User License – $4000
Buy Report Now!
About Market Research HUB : Market Research HUB is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments. Contact– 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : sales@marketresearchhub.com Website : http://www.marketresearchhub.com/